Moxifloxacin Orion

Moxifloxacin, the active ingredient in Moxifloxacin Orion, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections in adults and is prescribed when the causative organisms are susceptible.

GNH USA supplies Moxifloxacin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat infections of the respiratory and other systems. - Community‑acquired bacterial pneumonia: eradicates the typical pathogens and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and bacterial load. - Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and skin‑structure infections: eliminates susceptible Gram‑positive and Gram‑negative bacteria. - Intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic organisms.

Moxifloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertiginous sensation. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome. - Clostridioides difficile colitis: severe diarrhea with abdominal pain. - Peripheral neuropathy: persistent numbness or tingling. - Hepatotoxicity: significant liver injury with jaundice.

Before prescribing Moxifloxacin, clinicians should consider patient‑specific factors and safety measures. - Assess cardiac history: avoid in patients with known QT prolongation. - Review tendon health: contraindicated in patients with recent tendon injury or steroid use. - Monitor renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic status: use with caution in liver disease. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Moxifloxacin can alter the pharmacokinetics of several co‑administered drugs, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption, separate dosing by at least 2 hours. - Warfarin: may increase INR, monitor coagulation parameters closely. - Theophylline: increased plasma levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - CYP1A2 substrates (e.g., caffeine, clozapine): may raise serum concentrations. - Statins (especially simvastatin): heightened risk of myopathy, consider alternative lipid‑lowering agents. - Antidiabetic agents (e.g., insulin, sulfonylureas): possible hypoglycemia, monitor glucose levels.